Clinical Trial Update: Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of autologous mesenchymal stem cells injected intracavernously for erectile dysfunction has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Autologous Mesenchymal Stem Cells (MSC) for intracavernous injection (mesenchymal stem cells)

Snippet

Sponsor: Pharmicell Co., Ltd. | Conditions: Erectile Dysfunction | Phase 2 | Status: COMPLETED